Gastoldi S - Search Results

1

In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies.

Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C, Galbusera M, Gastoldi S, Mundel P, Remuzzi G, Benigni A. Morigi M, et al. Among authors: gastoldi s. Am J Pathol. 2005 May;166(5):1309-20. doi: 10.1016/S0002-9440(10)62350-4. Am J Pathol. 2005. PMID: 15855633 Free PMC article.

2

Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.

Galbusera M, Buelli S, Gastoldi S, Macconi D, Angioletti S, Testa C, Remuzzi G, Morigi M. Galbusera M, et al. Among authors: gastoldi s. Xenotransplantation. 2005 Mar;12(2):110-20. doi: 10.1111/j.1399-3089.2005.00203.x. Xenotransplantation. 2005. PMID: 15693841

3

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.

Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C. Morigi M, et al. Among authors: gastoldi s. J Immunol. 2011 Jul 1;187(1):172-80. doi: 10.4049/jimmunol.1100491. Epub 2011 Jun 3. J Immunol. 2011. PMID: 21642543

4

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.

Perico L, Morigi M, Galbusera M, Pezzotta A, Gastoldi S, Imberti B, Perna A, Ruggenenti P, Donadelli R, Benigni A, Remuzzi G. Perico L, et al. Among authors: gastoldi s. Front Immunol. 2022 Mar 7;13:827146. doi: 10.3389/fimmu.2022.827146. eCollection 2022. Front Immunol. 2022. PMID: 35320941 Free PMC article.

5

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.

Ruiz-Torres MP, Casiraghi F, Galbusera M, Macconi D, Gastoldi S, Todeschini M, Porrati F, Belotti D, Pogliani EM, Noris M, Remuzzi G. Ruiz-Torres MP, et al. Among authors: gastoldi s. Thromb Haemost. 2005 Mar;93(3):443-52. doi: 10.1160/TH04-07-0450. Thromb Haemost. 2005. PMID: 15735793

6

Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.

Galbusera M, Bresin E, Noris M, Gastoldi S, Belotti D, Capoferri C, Daina E, Perseghin P, Scheiflinger F, Fakhouri F, Grünfeld JP, Pogliani E, Remuzzi G. Galbusera M, et al. Among authors: gastoldi s. Blood. 2005 Aug 1;106(3):925-8. doi: 10.1182/blood-2004-12-4885. Epub 2005 Apr 12. Blood. 2005. PMID: 15827129 Free article.

7

ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.

Rurali E, Banterla F, Donadelli R, Bresin E, Galbusera M, Gastoldi S, Peyvandi F, Underwood M, Remuzzi G, Noris M. Rurali E, et al. Among authors: gastoldi s. Clin J Am Soc Nephrol. 2015 Nov 6;10(11):2002-12. doi: 10.2215/CJN.01700215. Epub 2015 Sep 4. Clin J Am Soc Nephrol. 2015. PMID: 26342041 Free PMC article.

8

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.

Galbusera M, Noris M, Gastoldi S, Bresin E, Mele C, Breno M, Cuccarolo P, Alberti M, Valoti E, Piras R, Donadelli R, Vivarelli M, Murer L, Pecoraro C, Ferrari E, Perna A, Benigni A, Portalupi V, Remuzzi G. Galbusera M, et al. Among authors: gastoldi s. Am J Kidney Dis. 2019 Jul;74(1):56-72. doi: 10.1053/j.ajkd.2018.11.012. Epub 2019 Mar 7. Am J Kidney Dis. 2019. PMID: 30851964

9

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

Aiello S, Gastoldi S, Galbusera M, Ruggenenti P, Portalupi V, Rota S, Rubis N, Liguori L, Conti S, Tironi M, Gamba S, Santarsiero D, Benigni A, Remuzzi G, Noris M. Aiello S, et al. Among authors: gastoldi s. Blood Adv. 2022 Jan 8;6(3):866-881. doi: 10.1182/bloodadvances.2021005246. Blood Adv. 2022. PMID: 34852172 Free PMC article.

10

In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTS13 in thrombotic thrombocytopenic purpura.

Donadelli R, Banterla F, Galbusera M, Capoferri C, Bucchioni S, Gastoldi S, Nosari S, Monteferrante G, Ruggeri ZM, Bresin E, Scheiflinger F, Rossi E, Martinez C, Coppo R, Remuzzi G, Noris M; International Registry of Recurrent and Familial HUS/TTP. Donadelli R, et al. Among authors: gastoldi s. Thromb Haemost. 2006 Oct;96(4):454-64. Thromb Haemost. 2006. PMID: 17003922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page